Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 17

1.

Quantitative Profiling of Post-translational Modifications by Immunoaffinity Enrichment and LC-MS/MS in Cancer Serum without Immunodepletion.

Gu H, Ren JM, Jia X, Levy T, Rikova K, Yang V, Lee KA, Stokes MP, Silva JC.

Mol Cell Proteomics. 2016 Feb;15(2):692-702. doi: 10.1074/mcp.O115.052266. Epub 2015 Dec 3.

2.

Identification and Analysis of the SET-Domain Family in Silkworm, Bombyx mori.

Zhao H, Zheng C, Cui H.

Biomed Res Int. 2015;2015:161287. doi: 10.1155/2015/161287. Epub 2015 Oct 19.

3.

The Ino80 complex prevents invasion of euchromatin into silent chromatin.

Xue Y, Van C, Pradhan SK, Su T, Gehrke J, Kuryan BG, Kitada T, Vashisht A, Tran N, Wohlschlegel J, Peterson CL, Kurdistani SK, Carey MF.

Genes Dev. 2015 Feb 15;29(4):350-5. doi: 10.1101/gad.256255.114.

4.

Ash2L enables P53-dependent apoptosis by favoring stable transcription pre-initiation complex formation on its pro-apoptotic target promoters.

Mungamuri SK, Wang S, Manfredi JJ, Gu W, Aaronson SA.

Oncogene. 2015 May 7;34(19):2461-70. doi: 10.1038/onc.2014.198. Epub 2014 Jul 14.

5.

p53-mediated heterochromatin reorganization regulates its cell fate decisions.

Mungamuri SK, Benson EK, Wang S, Gu W, Lee SW, Aaronson SA.

Nat Struct Mol Biol. 2012 Apr 1;19(5):478-84, S1. doi: 10.1038/nsmb.2271.

6.

Exendin-4 increases histone acetylase activity and reverses epigenetic modifications that silence Pdx1 in the intrauterine growth retarded rat.

Pinney SE, Jaeckle Santos LJ, Han Y, Stoffers DA, Simmons RA.

Diabetologia. 2011 Oct;54(10):2606-14. doi: 10.1007/s00125-011-2250-1. Epub 2011 Jul 21.

7.

Epigenetic repression of regulator of G-protein signaling 2 promotes androgen-independent prostate cancer cell growth.

Wolff DW, Xie Y, Deng C, Gatalica Z, Yang M, Wang B, Wang J, Lin MF, Abel PW, Tu Y.

Int J Cancer. 2012 Apr 1;130(7):1521-31. doi: 10.1002/ijc.26138. Epub 2011 Jun 9.

8.

ABF1-binding sites promote efficient global genome nucleotide excision repair.

Yu S, Smirnova JB, Friedberg EC, Stillman B, Akiyama M, Owen-Hughes T, Waters R, Reed SH.

J Biol Chem. 2009 Jan 9;284(2):966-73. doi: 10.1074/jbc.M806830200. Epub 2008 Nov 6.

9.

Unlocking repression of the human luteinizing hormone receptor gene by trichostatin A-induced cell-specific phosphatase release.

Zhang Y, Liao M, Dufau ML.

J Biol Chem. 2008 Aug 29;283(35):24039-46. doi: 10.1074/jbc.M801878200. Epub 2008 Jul 2. Erratum in: J Biol Chem. 2008 Dec 26;283(52):36752.

10.

Development of type 2 diabetes following intrauterine growth retardation in rats is associated with progressive epigenetic silencing of Pdx1.

Park JH, Stoffers DA, Nicholls RD, Simmons RA.

J Clin Invest. 2008 Jun;118(6):2316-24. doi: 10.1172/JCI33655.

11.
12.

N-formylation of lysine in histone proteins as a secondary modification arising from oxidative DNA damage.

Jiang T, Zhou X, Taghizadeh K, Dong M, Dedon PC.

Proc Natl Acad Sci U S A. 2007 Jan 2;104(1):60-5. Epub 2006 Dec 26.

13.

A role for chromosomal protein HMGN1 in corneal maturation.

Birger Y, Davis J, Furusawa T, Rand E, Piatigorsky J, Bustin M.

Differentiation. 2006 Feb;74(1):19-29.

15.

Human histone chaperone nucleophosmin enhances acetylation-dependent chromatin transcription.

Swaminathan V, Kishore AH, Febitha KK, Kundu TK.

Mol Cell Biol. 2005 Sep;25(17):7534-45.

16.

Specificity and mechanism of the histone methyltransferase Pr-Set7.

Xiao B, Jing C, Kelly G, Walker PA, Muskett FW, Frenkiel TA, Martin SR, Sarma K, Reinberg D, Gamblin SJ, Wilson JR.

Genes Dev. 2005 Jun 15;19(12):1444-54. Epub 2005 Jun 2.

17.

Supplemental Content

Support Center